Coadministration of Chemokine Receptor Antagonists with Morphine Potentiates Morphine's Analgesic Effect on Incisional Pain in Rats.

Author: AdlerMartin W, ChenXiaohong, CowanAlan, DouraMenahem, EisensteinToby K, GellerEllen B, InanSaadet, MeisslerJoseph J, RawlsScott M, TallaridaChristopher S, WatsonMia N

Paper Details 
Original Abstract of the Article :
Crossdesensitization between opioid and chemokine receptors and involvement of chemokines in pain modulation are well established. We investigated if coadministration of chemokine receptor antagonists (CRAs) with morphine would enhance the analgesic potency of morphine on incisional pain in rats. An...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226546/

データ提供:米国国立医学図書館(NLM)

Chemokine Receptor Antagonists: Enhancing Morphine’s Analgesic Effects

This study examines the synergistic effects of chemokine receptor antagonists (CRAs) in combination with morphine for pain management. The researchers used a [research methodology] to evaluate the analgesic effects of morphine, maraviroc (a CCR5 antagonist), AMD3100 (a CXCR4 antagonist), and their combinations in rats undergoing incisional surgery. The study's findings suggest that coadministering CRAs with morphine significantly potentiates the analgesic effects of morphine, implying a potential strategy for optimizing pain management.

A New Approach to Pain Management

The study's findings suggest a promising approach to managing pain effectively while minimizing the potential side effects associated with morphine. By combining CRAs with morphine, clinicians can achieve the same analgesic effects with lower doses of morphine, potentially reducing the risk of opioid tolerance and dependence. This synergistic approach to pain management could offer a more personalized and effective treatment strategy for patients.

Navigating the Challenges of Pain Management

The desert of pain can be a daunting landscape, often difficult to navigate. This research offers a new oasis of knowledge, highlighting the potential of combining chemokine receptor antagonists with morphine to enhance pain management. This approach could lead to more effective and safer pain management strategies, offering hope for a more comfortable journey through the desert of pain.

Dr.Camel's Conclusion

Just as a caravan relies on the collective strength of its members to traverse the desert, this research reveals the power of combining different medications to achieve optimal results. The synergy between CRAs and morphine holds exciting possibilities for pain management, offering a more effective and potentially safer approach for alleviating suffering and restoring comfort.

Date :
  1. Date Completed 2019-10-04
  2. Date Revised 2019-12-01
Further Info :

Pubmed ID

30249618

DOI: Digital Object Identifier

PMC6226546

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.